Literature DB >> 25399554

Endoscopic imaging in Barrett's esophagus.

Rajvinder Singh1, Sze Pheh Yeap.   

Abstract

Barrett's esophagus is the only known precursor that predisposes patients to the development of esophageal adenocarcinoma. The current recommended surveillance method is targeted biopsies of any abnormalities followed by random four-quadrant biopsies every 2 cm using standard white light endoscopy. Compliance with this and sampling error are two of the biggest problems. Several novel imaging technologies have been developed to aid the diagnosis of early neoplasia in Barrett's esophagus. There are emerging data that some of these new modalities can increase the yield of detecting dysplasia. This review will discuss some of the present available techniques and technologies including chromoendoscopy, narrow-band imaging, autofluorescence imaging, optical coherence tomography, confocal endomicroscopy and endocytoscopy. Based on the current evidence, these imaging modalities appear to be promising as adjunctive tools to white light endoscopy. A few of them, nevertheless, remain experimental due to expense, lack of expertise, generalizability as well as reproducibility of results.

Entities:  

Keywords:  Barrett’s esophagus; acetic acid; autofluorescence imaging; chromoendoscopy; confocal endomicroscopy; endocystoscopy; indigo carmine; methylene blue; narrow-band imaging; optical coherence tomography

Mesh:

Year:  2014        PMID: 25399554     DOI: 10.1586/17474124.2015.983080

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  2 in total

1.  In-vivo Barrett's esophagus digital pathology stage classification through feature enhancement of confocal laser endomicroscopy.

Authors:  Noha Ghatwary; Amr Ahmed; Enrico Grisan; Hamid Jalab; Luc Bidaut; Xujiong Ye
Journal:  J Med Imaging (Bellingham)       Date:  2019-03-05

2.  Esophageal cancer: Epidemiology, risk factors and screening.

Authors:  Jiang Li; Jianguo Xu; Yadi Zheng; Ya Gao; Siyi He; He Li; Kaiyong Zou; Ni Li; Jinhui Tian; Wanqing Chen; Jie He
Journal:  Chin J Cancer Res       Date:  2021-10-31       Impact factor: 4.026

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.